Yes, many healthy women can take HRT for the rest of their lives, and the newest research from 2024 to 2026 makes a stronger case for that than any guidance in the past two decades.
There’s no official expiration date written into the medical guidelines.
What matters is that you and your provider keep reviewing your symptoms, your health history, and your labs together, not that you stop on a set calendar date.
Can You Take HRT for the Rest of Your Life?
Yes.
For most healthy women, hormone replacement therapy (HRT) doesn’t need to stop after a set number of years.
The North American Menopause Society states that hormone therapy can continue well past age 60 or 65 for women who are still symptomatic and have no new health concerns, as long as the decision is reviewed regularly with a provider.
That’s a real shift from what many women were told a decade or two ago.
Some providers used to recommend stopping hormone therapy after about five years, almost as a routine rule rather than a decision based on your specific health.
Today’s guidance looks at your actual risk factors, not just a number on the calendar.
Most women who start HRT for hot flashes, night sweats, or other menopause symptoms do stop within two to five years, simply because their symptoms fade.
But fading symptoms aren’t the same as a required stop date.
Plenty of women keep taking hormone therapy well into their sixties, seventies, and beyond because it continues to help them, and their provider agrees it’s still the right call.
GET HELP WITH YOUR MENOPAUSE SYMPTOMS
Why Did Doctors Used to Say to Stop HRT After a Few Years?
The hesitation around long-term HRT traces back to 2002, when a major U.S. trial called the Women’s Health Initiative was stopped early.
Researchers were worried that hormone therapy was raising the risk of breast cancer, heart attack, and stroke in participants.
That trial scared a lot of people away from hormone therapy overnight, including many doctors.
Prescriptions dropped sharply, and a generation of women either never started HRT or quit it as soon as they could.
Years later, researchers took a closer look at who was actually in that trial.
Many participants were well into their sixties and had already gone through menopause a decade or more earlier before they started hormone therapy.
When scientists reanalyzed the data by age and time since menopause, a clearer picture emerged: starting hormone therapy soon after menopause carries a very different risk profile than starting it many years later.
That finding is now known as the timing hypothesis, and it reshaped how doctors think about HRT.
What Does the Newest Research Say About Long-Term HRT Use?
Research published between 2024 and 2026 is more reassuring about long-term hormone therapy than anything that’s come out since the early 2000s.
Multiple large studies now link ongoing estrogen therapy to lower rates of death, bone fracture, and cognitive decline, particularly in women who started treatment close to menopause and have stayed on it under medical supervision.
Heart and Longevity Benefits
A 2024 analysis from Harvard researchers, based on two decades of Women’s Health Initiative data, found that women under 60 who use hormone therapy see a 25 to 50 percent reduction in fatal cardiovascular events compared with women who don’t use it.
The benefits aren’t limited to younger women either.
A separate 2024 study that tracked prescription records for 10 million women on Medicare found that estrogen-only therapy used beyond age 65 was tied to a 19 percent lower risk of death from any cause, along with lower rates of heart failure, several cancers, and dementia.
Bone and Fracture Protection
Hormone therapy has long been known to help protect bone density, and recent data backs that up even more strongly.
A 2026 study presented at the Endocrine Society’s annual meeting found that women on menopausal hormone therapy had a 69 percent lower risk of low bone mineral density compared with women who weren’t using it.
A separate real-world study of more than 137,000 postmenopausal women found that starting hormone therapy early reduced the risk of fracture by 13 percent.
Other research suggests that protection fades once treatment stops.
Women who discontinued hormone therapy saw their fracture risk climb back up, which is one reason some women choose to stay on it longer than they originally planned.
Brain and Mood Benefits
The same 2024 Harvard analysis found that women under 60 using hormone therapy had a 64 percent reduction in cognitive decline and a 35 percent lower risk of Alzheimer’s disease compared with non-users.
Hormones also affect mood in ways that go beyond hot flashes.
If anxiety or low mood showed up around the same time as your other menopause symptoms, it’s worth looking at whether hormone-related mood changes are part of what you’re feeling, since that connection often gets missed.
Is There an Age Limit for Staying on HRT?
No single age automatically disqualifies someone from hormone therapy.
The safest window to start is before age 60 or within 10 years of your last period, but women who are already doing well on hormone therapy don’t have to stop just because they turn 60 or 65.
The North American Menopause Society’s 2022 position statement specifically states that hormone therapy doesn’t need to be routinely discontinued at age 60 or 65 and can be continued beyond 65 for persistent hot flashes, quality of life, or bone protection, after a provider reviews the benefits and risks with you.
That’s not just theoretical.
A review of women in their seventies and eighties who were still on hormone therapy found that many had been taking it for an average of 18 years, with over 40 percent on it for 20 years or longer.
The most common reasons were ongoing hot flashes and a better quality of life, and researchers found no strokes, heart attacks, or uterine cancers in that group.
What Are the Risks of Taking HRT Long-Term?
The main long-term risks are a small increase in breast cancer risk with combined estrogen-progestogen therapy, a higher chance of blood clots and stroke with oral forms, and thinner research data the longer someone stays on treatment.
None of that means hormone therapy is risk-free, and it’s worth seeing what those risks actually look like in numbers, not just in general warnings.
The biggest concern most women ask about is breast cancer.
The North American Menopause Society puts the added risk at less than one additional case per 1,000 women per year of hormone therapy use, rising to about three additional cases per 1,000 women after five years of combined estrogen-progestogen therapy.
Estrogen-only therapy, used by women who’ve had a hysterectomy, doesn’t carry that same increase and may even lower breast cancer risk slightly.
Blood clots, stroke, and gallbladder issues are also more common with oral hormone therapy than with other delivery methods.
That risk tends to climb somewhat with age and with how long someone has been taking oral estrogen, which is part of why ongoing reviews matter more than a one-time prescription.
The honest answer is that research on hormone therapy used for 20, 30, or more years is still thinner than research on the first 5 to 10 years.
Most major studies follow women for a decade or two, not a lifetime, so providers rely on a mix of long-term data, your personal and family health history, and yearly check-ins to make the call together.
How Do You Know If You Should Keep Taking HRT or Stop?
There’s no single test that tells you to stop.
Instead, you and your provider look at three things together each year: whether your symptoms are still better with treatment, whether any new health conditions have come up, and whether your current dose and delivery method still make sense for your life.
Signs It May Be Time to Reassess
A few situations are worth bringing up at your next visit instead of waiting for your annual review:
- A new diagnosis of a blood clot, certain cancers, liver disease, or unexplained vaginal bleeding
- Side effects that feel worse than the symptoms HRT was treating in the first place
- Major changes in your overall health, weight, or medication list
- Feeling unsure whether your current dose still fits your needs, especially if symptoms have crept back
If you’re early in treatment and still working out whether it’s helping, it also helps to know how long it typically takes to feel a difference on HRT before deciding whether to adjust your plan.
How Tapering Off Works If You Choose to Stop
Tapering off gradually is usually easier on your body than quitting all at once.
Lowering your dose slowly over weeks or months tends to reduce the chance of symptoms rushing back all at once.
One exception worth knowing: vaginal estrogen, used for dryness and discomfort, doesn’t carry the same systemic risks as other forms of HRT.
Many women keep using it indefinitely, even after stopping other hormone therapy.
Does the Type of HRT You Take Change the Answer?
Yes, somewhat.
Not all hormone therapy carries the exact same long-term profile.
The 2024 Medicare study found that delivery method mattered.
Vaginal estrogen was linked to a 30 percent reduction in mortality risk, transdermal (patch or gel) estrogen to 20 percent, and oral estrogen to 11 percent, likely because non-oral forms skip the liver processing that raises clotting risk.
Estradiol, the form of estrogen that’s chemically identical to what your body makes, showed a bigger mortality benefit than conjugated equine estrogen in that same study.
This is also where the bioidentical hormone conversation comes in.
FDA-approved bioidentical hormones go through the same safety testing as any other prescription medication.
Compounded versions made at specialty pharmacies don’t go through that same FDA review, so it’s worth asking your provider which category any compounded product falls into before assuming it carries less long-term risk.
How First Call DPC Helps You Make This Decision With Confidence
Deciding whether to keep taking hormone therapy isn’t a one-time choice.
It’s something that deserves a real conversation every year, not a form you fill out while a provider glances at the clock.
At First Call DPC, personalized hormone replacement therapy for women starts with a full look at your hormone levels, symptoms, and health history, not a one-size-fits-all dose.
Because our direct primary care membership includes unlimited visits and messaging, adjusting your plan doesn’t mean waiting months for the next available appointment.
We also take a functional medicine approach to menopause that looks at hormone therapy as one part of a bigger picture, alongside nutrition, stress, sleep, and thyroid health.
Whether you’re just starting to notice perimenopause symptoms or you’ve been on hormone therapy for years and want a second opinion on whether to continue, that ongoing relationship is what makes long-term decisions feel safer than guessing on your own.
The Bottom Line
Most healthy women can take HRT for as long as it continues to help them, with no fixed expiration date written into current medical guidelines.
The real work is staying engaged with that decision each year instead of treating it as a one-time prescription.
If you’re trying to figure out whether continuing hormone therapy is still right for you, or you’re just getting started and want a plan built around your own labs and history rather than a generic protocol, First Call DPC’s physicians are here to work through it with you.
FAQs: Can You Take HRT for the Rest of Your Life
Is it safe to take HRT for 20 years or more?
For many healthy women, yes, especially if treatment started close to menopause and has been reviewed regularly. Long-term data is still more limited for 20-plus years compared with the first decade, so providers lean on annual check-ins, your personal health history, and current research to make that call with you rather than assuming safety indefinitely.
What happens if you stop HRT suddenly?
Stopping abruptly can bring menopause symptoms like hot flashes and night sweats back quickly, sometimes more intensely than before. That’s why tapering the dose down gradually, rather than quitting all at once, is the more comfortable approach for most women.
Does bioidentical HRT carry the same long-term risks as synthetic versions?
FDA-approved bioidentical hormones have gone through the same clinical testing and regulation as other prescription hormone therapy, so the long-term risk data generally applies to them too. Compounded bioidentical hormones from specialty pharmacies haven’t gone through that same FDA review process, which makes their long-term safety data less complete.
Can you switch from combined HRT to estrogen-only therapy later on?
That depends on your individual health history, including whether you still have a uterus, since estrogen-only therapy without progesterone can raise the risk of uterine cancer in women who haven’t had a hysterectomy. This is a conversation to have directly with your provider rather than a switch to make on your own.